DenseNet and Support Vector Machine classifications of major depressive disorder using vertex-wise cortical features
Authors:
Vladimir Belov,
Tracy Erwin-Grabner,
Ling-Li Zeng,
Christopher R. K. Ching,
Andre Aleman,
Alyssa R. Amod,
Zeynep Basgoze,
Francesco Benedetti,
Bianca Besteher,
Katharina Brosch,
Robin Bülow,
Romain Colle,
Colm G. Connolly,
Emmanuelle Corruble,
Baptiste Couvy-Duchesne,
Kathryn Cullen,
Udo Dannlowski,
Christopher G. Davey,
Annemiek Dols,
Jan Ernsting,
Jennifer W. Evans,
Lukas Fisch,
Paola Fuentes-Claramonte,
Ali Saffet Gonul,
Ian H. Gotlib
, et al. (63 additional authors not shown)
Abstract:
Major depressive disorder (MDD) is a complex psychiatric disorder that affects the lives of hundreds of millions of individuals around the globe. Even today, researchers debate if morphological alterations in the brain are linked to MDD, likely due to the heterogeneity of this disorder. The application of deep learning tools to neuroimaging data, capable of capturing complex non-linear patterns, h…
▽ More
Major depressive disorder (MDD) is a complex psychiatric disorder that affects the lives of hundreds of millions of individuals around the globe. Even today, researchers debate if morphological alterations in the brain are linked to MDD, likely due to the heterogeneity of this disorder. The application of deep learning tools to neuroimaging data, capable of capturing complex non-linear patterns, has the potential to provide diagnostic and predictive biomarkers for MDD. However, previous attempts to demarcate MDD patients and healthy controls (HC) based on segmented cortical features via linear machine learning approaches have reported low accuracies. In this study, we used globally representative data from the ENIGMA-MDD working group containing an extensive sample of people with MDD (N=2,772) and HC (N=4,240), which allows a comprehensive analysis with generalizable results. Based on the hypothesis that integration of vertex-wise cortical features can improve classification performance, we evaluated the classification of a DenseNet and a Support Vector Machine (SVM), with the expectation that the former would outperform the latter. As we analyzed a multi-site sample, we additionally applied the ComBat harmonization tool to remove potential nuisance effects of site. We found that both classifiers exhibited close to chance performance (balanced accuracy DenseNet: 51%; SVM: 53%), when estimated on unseen sites. Slightly higher classification performance (balanced accuracy DenseNet: 58%; SVM: 55%) was found when the cross-validation folds contained subjects from all sites, indicating site effect. In conclusion, the integration of vertex-wise morphometric features and the use of the non-linear classifier did not lead to the differentiability between MDD and HC. Our results support the notion that MDD classification on this combination of features and classifiers is unfeasible.
△ Less
Submitted 18 November, 2023;
originally announced November 2023.
Multi-site benchmark classification of major depressive disorder using machine learning on cortical and subcortical measures
Authors:
Vladimir Belov,
Tracy Erwin-Grabner,
Ali Saffet Gonul,
Alyssa R. Amod,
Amar Ojha,
Andre Aleman,
Annemiek Dols,
Anouk Scharntee,
Aslihan Uyar-Demir,
Ben J Harrison,
Benson M. Irungu,
Bianca Besteher,
Bonnie Klimes-Dougan,
Brenda W. J. H. Penninx,
Bryon A. Mueller,
Carlos Zarate,
Christopher G. Davey,
Christopher R. K. Ching,
Colm G. Connolly,
Cynthia H. Y. Fu,
Dan J. Stein,
Danai Dima,
David E. J. Linden,
David M. A. Mehler,
Edith Pomarol-Clotet
, et al. (41 additional authors not shown)
Abstract:
Machine learning (ML) techniques have gained popularity in the neuroimaging field due to their potential for classifying neuropsychiatric disorders. However, the diagnostic predictive power of the existing algorithms has been limited by small sample sizes, lack of representativeness, data leakage, and/or overfitting. Here, we overcome these limitations with the largest multi-site sample size to da…
▽ More
Machine learning (ML) techniques have gained popularity in the neuroimaging field due to their potential for classifying neuropsychiatric disorders. However, the diagnostic predictive power of the existing algorithms has been limited by small sample sizes, lack of representativeness, data leakage, and/or overfitting. Here, we overcome these limitations with the largest multi-site sample size to date (n=5,356) to provide a generalizable ML classification benchmark of major depressive disorder (MDD). Using brain measures from standardized ENIGMA analysis pipelines in FreeSurfer, we were able to classify MDD vs healthy controls (HC) with around 62% balanced accuracy, but when harmonizing the data using ComBat balanced accuracy dropped to approximately 52%. Similar results were observed in stratified groups according to age of onset, antidepressant use, number of episodes and sex. Future studies incorporating higher dimensional brain imaging/phenotype features, and/or using more advanced machine and deep learning methods may achieve more encouraging prospects.
△ Less
Submitted 25 October, 2022; v1 submitted 16 June, 2022;
originally announced June 2022.